Literature DB >> 26786863

Evolutionary Rationale for Phages as Complements of Antibiotics.

Clara Torres-Barceló1, Michael E Hochberg2.   

Abstract

Antibiotic-resistant bacterial infections are a major concern to public health. Phage therapy has been proposed as a promising alternative to antibiotics, but an increasing number of studies suggest that both of these antimicrobial agents in combination are more effective in controlling pathogenic bacteria than either alone. We advocate the use of phages in combination with antibiotics and present the evolutionary basis for our claim. In addition, we identify compelling challenges for the realistic application of phage-antibiotic combined therapy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibiotic resistance; combined therapies; evolution; phage therapy

Mesh:

Substances:

Year:  2016        PMID: 26786863     DOI: 10.1016/j.tim.2015.12.011

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  78 in total

Review 1.  Ecology of the Oral Microbiome: Beyond Bacteria.

Authors:  Jonathon L Baker; Batbileg Bor; Melissa Agnello; Wenyuan Shi; Xuesong He
Journal:  Trends Microbiol       Date:  2017-01-11       Impact factor: 17.079

2.  Targeting antibiotic resistant bacteria with phage reduces bacterial density in an insect host.

Authors:  Lauri Mikonranta; Angus Buckling; Matti Jalasvuori; Ben Raymond
Journal:  Biol Lett       Date:  2019-03-29       Impact factor: 3.703

3.  Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.

Authors:  Pauline D Scanlan; Anna M Bischofberger; Alex R Hall
Journal:  FEMS Microbiol Ecol       Date:  2016-10-12       Impact factor: 4.194

Review 4.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

Review 5.  Phage therapy for respiratory infections.

Authors:  Rachel Yoon Kyung Chang; Martin Wallin; Yu Lin; Sharon Sui Yee Leung; Hui Wang; Sandra Morales; Hak-Kim Chan
Journal:  Adv Drug Deliv Rev       Date:  2018-08-07       Impact factor: 15.470

6.  Bacteriophage AB-SA01 Cocktail in Combination with Antibiotics against MRSA-VISA Strain in an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Razieh Kebriaei; Katherine L Lev; Kyle C Stamper; Susan M Lehman; Sandra Morales; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

7.  Spinal Cord Injury Creates Unique Challenges in Diagnosis and Management of Catheter-Associated Urinary Tract Infection.

Authors:  Felicia Skelton-Dudley; James Doan; Katie Suda; S Ann Holmes; Charlesnika Evans; Barbara Trautner
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

8.  Phage cocktail SalmoFREE® reduces Salmonella on a commercial broiler farm.

Authors:  V Clavijo; D Baquero; S Hernandez; J C Farfan; J Arias; A Arévalo; P Donado-Godoy; M Vives-Flores
Journal:  Poult Sci       Date:  2019-10-01       Impact factor: 3.352

Review 9.  Steering Phages to Combat Bacterial Pathogens.

Authors:  James Gurney; Sam P Brown; Oliver Kaltz; Michael E Hochberg
Journal:  Trends Microbiol       Date:  2019-11-16       Impact factor: 17.079

10.  High-throughput mapping of the phage resistance landscape in E. coli.

Authors:  Vivek K Mutalik; Benjamin A Adler; Harneet S Rishi; Denish Piya; Crystal Zhong; Britt Koskella; Elizabeth M Kutter; Richard Calendar; Pavel S Novichkov; Morgan N Price; Adam M Deutschbauer; Adam P Arkin
Journal:  PLoS Biol       Date:  2020-10-13       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.